Pérez VDR

Language: Spanish
References: 17
Page:
PDF size: 70.08 Kb.

ABSTRACT

Objective: An approach to the perspective of Health Diplomacy was carried out as well as the real possibilities that it will be a solution that correlates the global health system with international relations. Method: Prospective longitudinal descriptive study. Results: In contrast to the scientific and technical development achieved at present, in several Third Word Countries, some pandemics prevail which are considered a threat if necessary measures are not taken with the political willingness that this situation deserves. In this sense, some academic societies and international institutions have released the term Health Diplomacy as a tool to be employed by politicians, diplomats and officials of non-governmental organizations to raise consciousness in societies that have the economic power to support measures to counteract the negative impact of these diseases. Conclusions: This initiative, in principle, has not been implemented equally with positive interests, by determined governments and institutions that are involved in this issue.

REFERENCES

1. Aguilar-Morales, J.E. Evolución y desarrollo de las políticas públicas en salud. México: Asociación Oaxaqueña de Psicología A.C. (2006) Disponible en http://www.conductitlan.net/historia.ppt

2. Amorim, C. Douste-Blazy, P., Wirayuda, H., Store, J., Gadio, C., Dlamini-Zuma, N., Pibulsonggram, N. Oslo Ministerial Declaration global health: a pressing foreignpolicyissue of our time. TheLancet, v.369, n.9570, p. 1373-1378, 2007.

3. Auer A, Guerrero Espinel JE. La Organización Panamericana de la Salud y la salud internacional: una historia de formación, conceptualización y desarrollo colectivo. RevPanam Salud Pública. 2011;30(2):11121.

4. Feldbaum H, Michaud J HealthDiplomacy and theEnduringRelevance of ForeignPolicyInterests. PLoSMed 7(4): e1000226. doi:10.1371/journal.pmed.1000226. 2010.

5. González Miranda, B. Medicalización, iatrogenia y ética de las relaciones con la industria farmacéutica. Máster Interuniversitario de Bioética (IIIª edición), noviembre 2009

6. Keck W. Cuba'scontributionto Global HealthDiplomacy. GHD Workshop Marzo 2007.

7. Kickbusch, I. Global HealthDiplomacy. Seminario Health as ForeingPolicy. Universidad de Oslo, Noviembre 2009.

8. Kickbusch, I., G. Silberschmidt& P. Buss. Global HealthDiplomacy: theneedfor new perspectives, strategicapproaches and skills in global health. Bulletin of the WHO 85(3): 161-244. 2007.

9. MarchioriBuss P, do Carmo Leal M. Global Health and HealthDiplomacy. Cad. Saúde Pública vol.25 no.12 Rio de Janeiro Dec. 2009.

10. Meeting de Expertos. HarnessingthePower of Business forBetter Global HealthDiplomacy in Non-CommunicableDiseasePrevention and Control. McGillWorldPlatformforHealth and EconomicConvergenceThinkTank. 2009.

11. Melé D. Las cinco mayores compañias farmacéuticas: imagen corporativa y crítica en responsabilidad social. Cátedra Economía y Etica, Universidad de Navarra , España, 2006.

12. Mittelman JH. El síndrome de la globalización. Transformación y resistencia. Editorial Siglo XXI Barcelona, España.

13. Resolución 63/33 Global health and foreignpolicy. Asamblea General de Naciones Unidad (2009). Disponible en el sitio web: http://www.who.int/entity/trade/events/UNGA_RESOLUTION_GHFP_63_ 33.pdf. Accessed 2 August 2009.

14. Organización Panamericana de la Salud. Resolución del 48vo Consejo Directivo de la OPS. La Salud y las Relaciones Internacionales. Su vinculación con la gestión del desarrollo nacional.

15. Ríos M, Monleón-Getino T. A graphicalstudy of tuberculosis incidence and trends in theWHO'sEuropeanregion (1980-2006). Europ J Epidemiol. 2009

16. Sridhar D. ForeignPolicy and Global Health: Country Strategies. Prince MahidolAwardsConference, Jan 28-30 2008.

17. Organización Mundial de la Salud. TheSelection And Use Of Essential Medicines. Report of the WHO ExpertCommittee. TechnicalReport Series No 914. WHO, Geneva. 2003